Name | Type | Posted | Actions |
|---|---|---|---|
Att 22_Schedule of Contract Prices.xlsx | XLSX | Sep 14, 2022 | |
Att 1_Packaging and Delivery of Proposals for Use with the NIH eCPS website.docx | DOCX | Sep 14, 2022 | |
Att 2_intent.pdf | Sep 14, 2022 | ||
Att 3 - SOW final.pdf | Sep 14, 2022 | ||
Att 4 - Property.pdf | Sep 14, 2022 | ||
Att 5_Section K.pdf | Sep 14, 2022 | ||
Att 13_Wage Determination.pdf | Sep 14, 2022 | ||
Att 15_Invoicing Instructions Without IPP Updated 8-15-22.docx | DOCX | Sep 14, 2022 | |
Att 15_NIH(RC)2 Final.pdf | Sep 14, 2022 | ||
Att 21_Sample TO with Year 1 Contract Prices.pdf | Sep 14, 2022 | ||
RFP_75N95022R00097.pdf | Sep 14, 2022 |
NIDA Center for Genetic Studies
Contact and place of performance
—
Not specified
No narrative description provided for this notice.
The National Institute on Drug Abuse (NIDA) issued solicitation number 75N95022R00097 to support the NIDA Center for Genetic Studies. This federal opportunity involves 11 attachments, including a final statement of work, a schedule of contract prices, property documentation, Section K representations and certifications, and instructions for the packaging and delivery of proposals via the NIH eCPS website. An intent to bid document was also included in the supplemental materials released during the solicitation period.
The procurement was published on August 15, 2022, and received its last update on October 14, 2022. This notice and its associated documentation are sourced from SAM.gov under the Department of Health and Human Services. No specific NAICS code, PSC code, or set-aside designation was identified in the provided notice metadata.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.